What is the ROE (Return on Equity) of MorphoSys this year?
The ROE of MorphoSys this year is -3.87 undefined.
MorphoSys ROE 2024
MorphoSys ROE
-3.87
Ticker
MOR.DE
ISIN
DE0006632003
WKN
663200
In 2024, MorphoSys's return on equity (ROE) was -3.87, a 303.09% increase from the -0.96 ROE in the previous year.
MorphoSys Aktienanalyse
What does MorphoSys do?
MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding MorphoSys's Return on Equity (ROE)
MorphoSys's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing MorphoSys's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
MorphoSys's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in MorphoSys’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about MorphoSys stock
How has the Return on Equity (ROE) of MorphoSys developed compared to the previous year?
The ROE of MorphoSys has increased by 303.09% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of MorphoSys?
A high ROE indicates that MorphoSys generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of MorphoSys?
A low ROE can indicate that MorphoSys is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of MorphoSys affect the company?
A change in ROE (Return on Equity) of MorphoSys can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of MorphoSys?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of MorphoSys?
Some factors that can influence MorphoSys's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does MorphoSys pay?
Over the past 12 months, MorphoSys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MorphoSys is expected to pay a dividend of 0 EUR.
What is the dividend yield of MorphoSys?
The current dividend yield of MorphoSys is .
When does MorphoSys pay dividends?
MorphoSys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MorphoSys?
MorphoSys paid dividends every year for the past 0 years.
What is the dividend of MorphoSys?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is MorphoSys located?
MorphoSys is assigned to the 'Health' sector.
Wann musste ich die Aktien von MorphoSys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MorphoSys from 12/20/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.
When did MorphoSys pay the last dividend?
The last dividend was paid out on 12/20/2024.
What was the dividend of MorphoSys in the year 2023?
In the year 2023, MorphoSys distributed 0 EUR as dividends.
In which currency does MorphoSys pay out the dividend?
The dividends of MorphoSys are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The MorphoSys stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von MorphoSys
Our stock analysis for MorphoSys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MorphoSys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
